Khi Pin Chua - Concepedia

Author

Khi Pin Chua

Genome Institute of Singapore ORCID

Also Known As

Chua, Khi Pin, Chua, Khi Pin., K. Chua, K.P. Chua, Khi Pin Chua

Publications

844

Citations

H-Index

Concepts

All Affiliations

Genome Institute of Singapore Singapore General Hospital National University Cancer Institute, Singapore Nanyang Technological University Agency for Science, Technology and Research

About

Khi Pin Chua is an author at Genome Institute of Singapore specializing in medicine, pathology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	706
2	Engineering	1	1	73
3	Natural Sciences	1	1	105
4	Hepatology	1	1	73
5	Molecular Biology	1	1	105

Khi Pin Chua

Publications

816

Citations

H-Index

Page 1

	Year	Citations
Genomic landscape of lung adenocarcinoma in East Asians Jianbin Chen, Hechuan Yang, Audrey Su Min Teo, Nature Genetics PathologyCancer GenomicsBronchial NeoplasmEast AsiansMedicine	2020	517
Characterization and visualization of tandem repeats at genome scale Egor Dolzhenko, Adam C. English, Harriet Dashnow, Nature Biotechnology Molecular EcologyNatural SciencesGeneticsGenome StructureMolecular Biology	2024	105
Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study Weiwei Zhai, Hannah Lai, Neslihan Arife Kaya, National Science Review EngineeringGeneticsPathologyIntra-tumor HeterogeneityTumor Biology	2021	73
Profilin Negatively Regulates Formin-Mediated Actin Assembly to Modulate PAMP-Triggered Plant Immunity He Sun, Qiao Zhu, Khi Pin Chua, Current Biology	2018	60
Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities Khi Pin Chua, Yvonne H.F. Teng, Aaron C. Tan, Clinical Cancer Research	2021	36
A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and ‘bad apple’ effect on clinical trajectory Jianbin Chen, Neslihan Arife Kaya, Ying Zhang, Journal of Hepatology	2024	14
P1.17-07 Neoadjuvant Gefitinib in Resectable Early Stage EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): A Window-of-Opportunity Study A. Tan, Khi Pin Chua, Angela Takano, Journal of Thoracic Oncology Surgical OncologyMedicinePathologyP1.17-07 Neoadjuvant GefitinibWindow-of-opportunity Study	2019	11

Page 1